These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8281235)

  • 1. [Vaginal contraception with ovarian steroids].
    Levrier M
    Contracept Fertil Sex; 1993 Nov; 21(11):837-8. PubMed ID: 8281235
    [No Abstract]   [Full Text] [Related]  

  • 2. [The desogestrel-ethinyl estradiol combination and overweight: current data].
    Rubio Lotvin B
    Ginecol Obstet Mex; 1995 Nov; 63():483-6. PubMed ID: 8537039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian activity and bleeding patterns during extended continuous use of a combined contraceptive vaginal ring.
    Davies GC; Feng LX; Newton JR; Dieben TO; Coelingh-Bennink HJ
    Contraception; 1992 Sep; 46(3):269-78. PubMed ID: 1451522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in contraception: a comprehensive review of Desogen (desogestrel and ethinyl estradiol).
    Lammers P; Blumenthal PD; Huggins GR
    Contraception; 1998 May; 57(5 Suppl):1S-27S. PubMed ID: 9673846
    [No Abstract]   [Full Text] [Related]  

  • 5. The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception.
    Schindler AE
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):13-4. PubMed ID: 8365506
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vaginal contraception: new form of administration of hormonal contraception].
    Knuist M; Hamerlynck JV
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2095-7. PubMed ID: 14619196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postcoital contraception using a desogestrel-ethinyl estradiol combination].
    Alovisi C; Pacilli L
    Minerva Ginecol; 1988 Feb; 40(2):109-11. PubMed ID: 2969465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the oral administration of a contraceptive on lipid balance and on the concentration of serum tocopherol].
    Martino F; Lapiana C; Di Salvo G; Galati G; Avitto P; Lubrano R
    Minerva Ginecol; 1988 Sep; 40(9):557-8. PubMed ID: 2975772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormonal contraception with gestagens].
    Petersen KR; Poulsen EF
    Ugeskr Laeger; 2001 Aug; 163(34):4553-6. PubMed ID: 11530558
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
    Roumen FJ; Dieben TO
    Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic studies with a new progestational substance -- ORG 2969 -- in combination with ethinyloestradiol.
    Alapiessa U; Assendorp R; Hirvonen E; Hulkko S; Järvi K; Korhonen M; Käär K; Lauslahti K; Liukko P; Lumiala I; Pora O; Punnonen R; Rhen K; Ruokonen A; Saranen M; Tarkkila T; Viinikka L; Virkkunen P; Weijers M; Widholm O
    Acta Obstet Gynecol Scand Suppl; 1979; 85():1-21. PubMed ID: 377898
    [No Abstract]   [Full Text] [Related]  

  • 13. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
    Haaland RE; Holder A; Evans-Strickfaden T; Nyagol B; Makanga M; Oyaro B; Humwa F; Williams T; McLellan-Lemal E; Desai M; Huey MJ
    Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH; Dieben TO
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuvaring is a novel contraception method].
    Dinov I; Batashki I; Ivanov S
    Akush Ginekol (Sofiia); 2007; 46 Suppl 2():45-46. PubMed ID: 18217305
    [No Abstract]   [Full Text] [Related]  

  • 16. [The procedure for treating patients with genital endometriosis].
    Ventskivs'ka IB
    Lik Sprava; 2000; (1):85-6. PubMed ID: 10878989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaginal contraception with steroids].
    Levrier M
    Contracept Fertil Sex (Paris); 1993 Nov; 21(11):837-8. PubMed ID: 12287400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
    Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
    Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The latest progestagens].
    Belaïsch J; Eliakim V
    Contracept Fertil Sex; 1993 Apr; 21(4):287-93. PubMed ID: 7951628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.